Fetal hemoglobin reactivation in baboon and man: a short perspective.
Present concepts of the mechanism of reactivation of synthesis of fetal hemoglobin (HbF) in the adult under conditions of erythropoietic stress are briefly reviewed. Since HbF can be considered an effective natural antisickling agent, the reactivation of its synthesis in patients with sickle cell anemia as a desirable therapeutic goal has been extensively explored since the discovery in 1982 that 5-azacytidine increases HbF levels in the baboon. Hydroxyurea (HU) has become the most widely used agent, although its effectiveness in increasing HbF levels and the number of F cells is highly variable. Recent investigations are cited showing that other agents such as butyrate, and the addition of recombinant hemopoietic growth factors, such as erythropoietin and stem cell factor, especially in combination with HU, offer important therapeutic possibilities. Transacting nuclear proteins are briefly discussed as possibly having a future role in the efforts of stimulating gamma-chain synthesis.
Lavelle
D
D
Department of Medicine, University of Illinois, Chicago College of Medicine.
DeSimone
J
J
Heller
P
P
D000755:Anemia, Sickle Cell / Q000097:blood; D000818:Animals; D001374:Azacitidine / Q000494:pharmacology; D002087:Butyrates / Q000494:pharmacology; D020148:Butyric Acid; D004921:Erythropoietin / Q000494:pharmacology; D005319:Fetal Hemoglobin / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology; D010215:Papio / Q000097:blood*
D002087:Butyrates; D020148:Butyric Acid; D004921:Erythropoietin; D005319:Fetal Hemoglobin; D001374:Azacitidine; D006918:Hydroxyurea